Endocyte Loss Narrows Amid Pending Acquisition

Posted: Updated:
(Image courtesy of Endocyte) (Image courtesy of Endocyte)
WEST LAFAYETTE -

West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) is reporting a third quarter net loss of $12.6 million, compared to a net loss of $23.3 million during the same period a year earlier. The biopharmaceutical company is in the midst of a proposed $2.1 billion acquisition by Switzerland-based Novartis AG, which is expected to close in the first half of next year. The deal is considered the largest of its kind ever for an Indiana life sciences company.

Chief Executive Officer Mike Sherman says "the team at Endocyte has always been passionate about developing innovative therapies to help change the treatment landscape for cancer patients, and we look forward to being able to leverage Novartis' global expertise and commitment to help realize this mission."

The company's research and development expenses more than doubled to $8.9 million in the quarter, compared to the third quarter last year. Endocyte expects cash, cash equivalents and investments balance at the end of the year to be greater than $310 million.

You can connect to more about the company's third quarter results by clicking here.

  • Perspectives

    • World Refugee Day Shines Light on Untapped Pool of Talented Workers

      From Fortune 500 companies to local small businesses, a similar theme rings true. In this strong economy where unemployment is low and growth is high, companies are competing for top talent. In Indianapolis - according to the U.S. Bureau of Labor and Statistics - unemployment is just 2.8 percent, and investment and job growth are on the rise. This is great news for Indianapolis-area residents looking for work or opportunities to advance their careers, but for businesses and...
    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Lilly Exec Named BioCrossroads CEO

      After a national search, BioCrossroads has announced Patty Martin will become the life science initiative's next president and chief executive officer. Martin, who most recently served as chief operating officer for Lilly Diabetes, will begin her new role Monday. She will become just the third CEO in the organization's 17-year history, and succeeds David Johnson, who in December announced plans to step down from the role to serve as president and CEO of the...

    • Mahan Named Community Health Network Executive Director

      Former Indiana State Representative Kevin Mahan has accepted the position of executive director, security and safety preparedness for Community Health Network. Mahan will be responsible for the strategic vision and day-to-day operations of the Network’s security services, disaster planning, emergency preparedness efforts, and network valet services. 

    • Holcomb will chair the 2019 conference, set for November 7 in Indianapolis.

      Janet Holcomb to Chair Conference For Women

      Indiana First Lady Janet Holcomb will serve as chair for this year's Indiana Conference for Women. Nearly 2,000 people are expected to attend the ninth annual conference, in Indianapolis in November. Holcomb's career includes a stint as vice president of her family's bolt and fastener manufacturing business, R&R Engineering. She has also led fundraising efforts for political campaigns as well as nonprofit organizations focusing in areas including animal welfare, arts and...

    • (file photo courtesy of Radial)

      Radial Opens Fulfillment Center in Brownsburg

      Pennsylvania-based Radial Inc. says its new fulfillment center in Brownsburg is now open. The e-commerce technology and operations company says the nearly 700,000-square-foot facility is the largest in its network and will have the capacity to house about 2,000 employees.

    • (rendering courtesy of Jones Development Co.)

      New Business Park Planned for Whiteland

      Missouri-based Jones Development Co. has begun construction on a new business park in Johnson County. The 2.4 million-square-foot Whiteland Exchange will be located on 167 acres near I-65 in Whiteland.  Financial terms of the developer's investment in the project were not disclosed. The business park is slated to include modern industrial buildings for logistics, advanced manufacturing and related uses. Work is underway on the first two speculative buildings, which total nearly...